Envista Holdings Management

Management criteria checks 3/4

Envista Holdings' CEO is Amir Aghdaei, appointed in Sep 2019, has a tenure of 4.58 years. total yearly compensation is $7.06M, comprised of 15.6% salary and 84.4% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth €3.50M. The average tenure of the management team and the board of directors is 3.7 years and 4.6 years respectively.

Key information

Amir Aghdaei

Chief executive officer

US$7.1m

Total compensation

CEO salary percentage	15.6%
CEO tenure	4.6yrs
CEO ownership	0.1%
Management average tenure	3.7yrs
Board average tenure	4.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Amir Aghdaei's remuneration changed compared to Envista Holdings's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	US$7m	US$1m	-US$100m
Sep 29 2023	n/a	n/a	US$191m
Jun 30 2023	n/a	n/a	US$219m
Mar 31 2023	n/a	n/a	US$211m
Dec 31 2022	US$9m	US$1m	US$238m
Sep 30 2022	n/a	n/a	US$207m
Jul 01 2022	n/a	n/a	US$238m
Apr 01 2022	n/a	n/a	US$272m
Dec 31 2021	US$9m	US$1m	US$264m
Oct 01 2021	n/a	n/a	US$312m
Jul 02 2021	n/a	n/a	US$256m
Apr 02 2021	n/a	n/a	US$122m
Dec 31 2020	US$7m	US$1m	US$43m
Oct 02 2020	n/a	n/a	US$8m
Jul 03 2020	n/a	n/a	US$46m
Apr 03 2020	n/a	n/a	US$163m
Dec 31 2019	US$8m	US$785k	US$184m
Sep 27 2019	n/a	n/a	US$213m
Jun 28 2019	n/a	n/a	US$215m
Mar 29 2019	n/a	n/a	US$232m
Dec 31 2018	US$7m	US$609k	US$231m
Dec 31 2017	US$4m	US$573k	US$301m

Compensation vs Market: Amir's total compensation ($USD7.06M) is above average for companies of similar size in the German market ($USD2.47M).

Compensation vs Earnings: Amir's compensation has been consistent with company performance over the past year.

CEO

Amir Aghdaei (64 yo)

4.6yrs

Tenure

US$7,059,325

Compensation

Mr. Amir Aghdaei has been President and Chief Executive Officer at Envista Holdings Corporation since September 20, 2019 and its Director since May 2019. Mr. Amir Aghdaei served as President and Group Exec...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Amir Aghdaei	President	4.6yrs	US$7.06m	0.11% $ 3.5m
Stephen Keller	VP of Investor Relations & Principal Financial Officer	3.1yrs	US$703.93k	0.0040% $ 128.9k
Mark Nance	Senior VP	4.6yrs	US$1.54m	0.016% $ 504.8k
Eric Conley	Senior VP & President of Orthodontics	4.3yrs	US$2.12m	0.012% $ 378.5k
Faez Kaabi	VP, Chief Accounting Officer & Corporate Controller	4.6yrs	no data	0.0059% $ 191.0k
Andrew Chen	Chief Information Officer	less than a year	no data	no data
Paul Sumilas	Chief Compliance Officer	less than a year	no data	no data
Mischa Reis	Senior Vice President of Strategy & Corporate Development	4.6yrs	no data	0.025% $ 824.4k
Suraj Satpathy	Chief Human Resources officer	less than a year	no data	no data
Filippo Impieri	Senior Vice President of Emerging Markets	no data	no data	no data
Claudia Ortiz	Senior Vice President of Regulatory Affairs & Quality Assurance	no data	no data	no data
David Armstrong	President of Restorative & Endodontics	2yrs	no data	no data

3.7yrs

Average Tenure

54yo

Average Age

Experienced Management: 0HV's management team is considered experienced (3.7 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Amir Aghdaei	President	4.9yrs	US$7.06m	0.11% $ 3.5m
Daniel Raskas	Independent Director	5.3yrs	US$285.05k	0% $ 0
Christine Tsingos	Independent Director	4.6yrs	US$310.05k	0% $ 0
Kieran Gallahue	Independent Director	4.3yrs	US$300.05k	0% $ 0
Barbara Hulit	Independent Director	2.3yrs	US$285.05k	0.0040% $ 129.9k
R. Huennekens	Independent Chairman of the Board	4.6yrs	US$435.09k	0% $ 0
Vivek Jain	Independent Director	4yrs	US$285.05k	0% $ 0
Wendy Carruthers	Independent Director	4.6yrs	US$305.05k	0.000010% $ 325.5

4.6yrs

Average Tenure

57.5yo

Average Age

Experienced Board: 0HV's board of directors are considered experienced (4.6 years average tenure).

Envista Holdings Management

Management criteria checks 3/4

Key information

Recent management updates

Envista Holdings Corporation Announces Chief Executive Officer Changes

Envista Holdings Corporation, Annual General Meeting, May 21, 2024

Insufficient new directors

Insufficient new directors

Envista Holdings Corporation Appoints Three New Members to Leadership Team

Insufficient new directors

Recent updates

Envista Holdings Corporation Announces Chief Executive Officer Changes

Envista Holdings Corporation, Annual General Meeting, May 21, 2024

Envista Holdings Corporation to Report Q1, 2024 Results on May 01, 2024

Insufficient new directors

Full year 2023 earnings released: US$0.60 loss per share (vs US$1.46 profit in FY 2022)

Insufficient new directors

Envista Holdings Corporation Provides Earnings Guidance for the Full Year 2024

Envista Holdings Corporation to Report Q4, 2023 Results on Feb 07, 2024

Envista Holdings Corporation Appoints Three New Members to Leadership Team

Insufficient new directors

New minor risk - Shareholder dilution

Third quarter 2023 earnings released: EPS: US$0.13 (vs US$0.30 in 3Q 2022)

Envista Holdings Corporation Provides Earnings Guidance for the Year 2023

Envista Holdings Corporation to Report Q3, 2023 Results on Nov 01, 2023

Insufficient new directors

Envista Holdings Corporation to Report Q2, 2023 Results on Aug 02, 2023

Insufficient new directors

Investor sentiment deteriorates as stock falls 16%

Envista Holdings Corporation Provides Earnings Guidance for the Year 2023

Envista Holdings Corporation to Report Q4, 2022 Results on Feb 08, 2023

Envista Holdings Corporation Provides Earnings Guidance for the Year 2022

Envista Holdings Corporation to Report Q3, 2022 Results on Nov 03, 2022

High number of new directors

Second quarter 2022 earnings released: EPS: US$0.27 (vs US$0.49 in 2Q 2021)

Envista Holdings Corporation Provides Sales Guidance for 2022

Envista Holdings Corporation Provides Sales Guidance for 2022

Envista Holdings Corporation to Report Q2, 2022 Results on Aug 03, 2022

Investor sentiment deteriorated over the past week

Envista Holdings Corporation (NYSE : NVST) agreed to acquire Osteogenics Biomedical, Inc., Allotech, LLC and OBI Biologics, Inc.

First quarter 2022 earnings released: EPS: US$0.43 (vs US$0.39 in 1Q 2021)

Envista Holdings Corporation Provides Unaudited Consolidated Impairment Charges for the First Quarter Ended April 1, 2022

High number of new and inexperienced directors

Envista Holdings Corporation (NYSE:NVST) completed the acquisition of Scanning Technology business of Carestream Dental LLC from Carestream Dental Parent Limited.

Envista Holdings Corporation to Report Q1, 2022 Results on May 04, 2022

Envista Holdings Corporation Announces Executive Changes

Envista Holdings Corporation Obtains FDA Clearance for Assisted Intelligence Mandibular Nerve Tracing

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Envista Holdings Corporation Receives FDA 510(k) Clearance for the Nobel Biocare N1™ Implant System

Envista Holdings Corporation (NYSE:NVST) entered into an agreement to acquire Scanning Technology business of Carestream Dental LLC for $600 million.

Third quarter 2021 earnings released: EPS US$0.50 (vs US$0.22 in 3Q 2020)

planmeca Verwaltungs GmbH entered into a binding agreement to acquire KaVo Dental Treatment Unit and Instrument Business for approximately $460 million.

Second quarter 2021 earnings released: EPS US$0.56 (vs US$0.59 loss in 2Q 2020)

First quarter 2021 earnings released: EPS US$0.45 (vs US$0.11 loss in 1Q 2020)

New 90-day high: €33.20

Insider recently sold €411k worth of stock

Envista Extends Partnership with Heartland Dental to Continue Providing Innovative Dental Solutions to Its Vast Network of Supported Doctors

Full year 2020 earnings released: EPS US$0.21 (vs US$1.60 in FY 2019)

Revenue beats expectations

New 90-day high: €31.80

Envista Holdings Corporation to Report Q4, 2020 Results on Feb 10, 2021

New 90-day high: €30.40

New 90-day high: €26.80

New 90-day high: €25.80

New 90-day high: €24.80

Third-quarter earnings released: Revenue beats expectations

Third quarter earnings released

Envista Holdings Corporation to Report Q3, 2020 Results on Oct 29, 2020

Envista Holdings Corporation Is Not Providing Guidance for 2020

New 90-day high - €20.80

Envista Holdings Corporation to Report Q2, 2020 Results on Jul 30, 2020

Envista Holdings Corporation(NYSE:NVST) dropped from Russell 2500 Growth Index

Envista Holdings Corporation(NYSE:NVST) dropped from Russell 3000 Growth Index

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure